The synergy between the two receptor pathways is present even at low doses, which is an argument for tirzepatide-based microdosing over semaglutide-based microdosing from a metabolic standpoint
We do not publish a self-administration amount the notes below are descriptive of supervised care, not a recommendation: Dosing Individualized by your prescribing provider and given as a subcutaneous injection
COA Testing Parameters Identity Verification HPLC and Mass Spectrometry confirm molecular structure Purity Analysis HPLC quantification, typically 98% Concentration Accuracy Verified dosing levels Molecular Weight Mass spectrometry confirmation Endotoxin Screening LAL assay, Bacterial Endotoxins Test Particulate Matter: Complies with USP Particulate Matter specifications FOR RESEARCH USE ONLY
Pharmacokinetic Interaction of astragaloside IV with atractylenolide I and prim-O-glucosylcimifugin in male Sprague Dawley rats
Supervision: HC, JG, OB, and NL
They help us distinguish between a real effect and a placebo or random chance